Evidence map›Paper›PMID 30297999›Full record

ReviewFrontiers in aging neuroscience2018

Astrocyte Activation and the Calcineurin/NFAT Pathway in Cerebrovascular Disease.

Susan D Kraner, Christopher M Norris

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. The CaJournal of virology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. HIV-1 Tat Upregulates TREM1 Expression in Human Microglia.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Calcineurin.Cell communication and signaling : CCS · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susan D KranerSanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, United States.
Christopher M NorrisSanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, United States.
University of Kentucky · US

Funding

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's diseaseR01AG056998 · NIA · UNIVERSITY OF KENTUCKY · PI Elizabeth Head, Christopher Mark Norris · 2017 to 2026
$5.3M
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's diseaseRF1AG056998 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI HEAD, ELIZABETH, NORRIS, CHRISTOPHER MARK · 2022 to 2022
$4.1M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseR01AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2006 to 2018
$3.2M
Calcineurin and inflammatory signaling processes in aging and Alzheimer's DiseaseRF1AG027297 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2018 to 2022
$2.6M
Astrocytic connexin 43 modulation in ADR21AG051945 · NIA · UNIVERSITY OF KENTUCKY · PI NORRIS, CHRISTOPHER MARK · 2017 to 2018
$414k
NIA NIH HHS R01 AG027297NIA NIH HHS R01 AG056998NIA NIH HHS R21 AG051945NIA NIH HHS RF1 AG027297NIA NIH HHS RF1 AG056998
6 · The paper itself

Abstract

Calcineurin (CN) is a Ca

Indexed as

Alzheimer’s diseaseCa2+excitotoxicitygliavascular contributions to cognitive impairment and dementia

Identifiers

PMID30297999
PMCPMC6160594
OpenAlexW2890680891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.